PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SLNO vs. TRML
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


SLNOTRML
YTD Return47.03%8.17%
1Y Return169.00%72.26%
3Y Return (Ann)73.28%-26.50%
Sharpe Ratio2.780.92
Sortino Ratio3.271.55
Omega Ratio1.391.23
Calmar Ratio1.730.88
Martin Ratio13.521.54
Ulcer Index12.37%48.51%
Daily Std Dev60.19%81.60%
Max Drawdown-99.86%-94.97%
Current Drawdown-90.98%-65.74%

Fundamentals


SLNOTRML
Market Cap$2.55B$737.48M
EPS-$2.79-$1.92
Total Revenue (TTM)$3.45M$2.28M
Gross Profit (TTM)$1.97M$1.12M
EBITDA (TTM)-$133.09M-$70.22M

Correlation

-0.50.00.51.00.2

The correlation between SLNO and TRML is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

SLNO vs. TRML - Performance Comparison

In the year-to-date period, SLNO achieves a 47.03% return, which is significantly higher than TRML's 8.17% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%100.00%JuneJulyAugustSeptemberOctoberNovember
38.27%
96.05%
SLNO
TRML

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SLNO vs. TRML - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and Tourmaline Bio Inc. (TRML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SLNO
Sharpe ratio
The chart of Sharpe ratio for SLNO, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.002.78
Sortino ratio
The chart of Sortino ratio for SLNO, currently valued at 3.27, compared to the broader market-4.00-2.000.002.004.006.003.27
Omega ratio
The chart of Omega ratio for SLNO, currently valued at 1.39, compared to the broader market0.501.001.502.001.39
Calmar ratio
The chart of Calmar ratio for SLNO, currently valued at 5.76, compared to the broader market0.002.004.006.005.76
Martin ratio
The chart of Martin ratio for SLNO, currently valued at 13.52, compared to the broader market0.0010.0020.0030.0013.52
TRML
Sharpe ratio
The chart of Sharpe ratio for TRML, currently valued at 0.92, compared to the broader market-4.00-2.000.002.004.000.92
Sortino ratio
The chart of Sortino ratio for TRML, currently valued at 1.55, compared to the broader market-4.00-2.000.002.004.006.001.55
Omega ratio
The chart of Omega ratio for TRML, currently valued at 1.23, compared to the broader market0.501.001.502.001.23
Calmar ratio
The chart of Calmar ratio for TRML, currently valued at 0.88, compared to the broader market0.002.004.006.000.88
Martin ratio
The chart of Martin ratio for TRML, currently valued at 1.54, compared to the broader market0.0010.0020.0030.001.54

SLNO vs. TRML - Sharpe Ratio Comparison

The current SLNO Sharpe Ratio is 2.78, which is higher than the TRML Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of SLNO and TRML, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
2.78
0.92
SLNO
TRML

Dividends

SLNO vs. TRML - Dividend Comparison

Neither SLNO nor TRML has paid dividends to shareholders.


TTM2023
SLNO
Soleno Therapeutics, Inc.
0.00%0.00%
TRML
Tourmaline Bio Inc.
0.00%57.75%

Drawdowns

SLNO vs. TRML - Drawdown Comparison

The maximum SLNO drawdown since its inception was -99.86%, which is greater than TRML's maximum drawdown of -94.97%. Use the drawdown chart below to compare losses from any high point for SLNO and TRML. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember0
-65.74%
SLNO
TRML

Volatility

SLNO vs. TRML - Volatility Comparison

The current volatility for Soleno Therapeutics, Inc. (SLNO) is 6.85%, while Tourmaline Bio Inc. (TRML) has a volatility of 13.50%. This indicates that SLNO experiences smaller price fluctuations and is considered to be less risky than TRML based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
6.85%
13.50%
SLNO
TRML

Financials

SLNO vs. TRML - Financials Comparison

This section allows you to compare key financial metrics between Soleno Therapeutics, Inc. and Tourmaline Bio Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items